← Leaderboards
Amy Rasley
Loyola University Chicago
$3,057,071
Attributed
$5,253,968
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $679.5K · FY2011–23$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,253,968 · 3
By mechanism
R01$3,295,345 · 1
U19$1,958,623 · 2
Top collaborators
- Adam Driks5 shared
- Paul Daniel Hoeprich5 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Adam Driks$3,097,278
- Paul Daniel Hoeprich$1,098,448
- Maurizio Bocchetta$1,786,710
- Melanie Dobbs Bird$52,346
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesAntigensMucous MembraneVaccinationIn VivoLaboratoriesVaccinatedResponseImmune ResponseBiologicalHuman ResourcesFertilizationBackAccreditationAnimalsExperimental StudyFormulationAtopobium VaginaeCellsCell Mediated Immune ResponseChlamydia TrachomatisCohortAnimal FacilityEfficacy Study
Grant awards (10)
Core 3. Immunology and Pathology.$471,359
U19 · FY2023 · AI · contact PI
Core 3. Immunology and Pathology.$388,129
U19 · FY2022 · AI · contact PI
Core 3. Immunology and Pathology.$459,485
U19 · FY2021 · AI · contact PI
Core 3. Immunology and Pathology.$139,829
U19 · FY2020 · AI · contact PI
Core 3. Immunology and Pathology.$499,821
U19 · FY2019 · AI · contact PI
A novel anti-spore nasal vaccine for protection from anthrax$663,922
R01 · FY2015 · AI
A novel anti-spore nasal vaccine for protection from anthrax$663,922
R01 · FY2014 · AI
A novel anti-spore nasal vaccine for protection from anthrax$624,087
R01 · FY2013 · AI
A novel anti-spore nasal vaccine for protection from anthrax$663,922
R01 · FY2012 · AI
A novel anti-spore nasal vaccine for protection from anthrax$679,492
R01 · FY2011 · AI